JNJ's Janssen Biotech unit requests FDA approval of Simponi, its investigational intravenous...
JNJ's Janssen Biotech unit requests FDA approval of Simponi, its investigational intravenous formulation for the treatment of adults with moderately to severely active rheumatoid arthritis.
From other sites
at Financial Times (Wed, 4:54AM)
at Nasdaq.com (Apr 27, 2015)
at Investopedia (Apr 10, 2015)
at 4-traders.com (Mar 24, 2015)
at Nasdaq.com (Mar 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs